Elevated homocysteine levels in young male patients with schizophrenia

American Journal of Psychiatry

Volumn 159, Issue 10, 2002, Pages 1790-1792

  Levine, Joseph ^a   Stahl, Ziva ^a   Sela, Ben Ami ^a   Gavendo, Slava ^a   Ruderman, Vladimir ^a   Belmaker, Robert H ^a  

^a MENTAL HEALTH CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

HOMOCYSTEINE;

ADULT; AGED; AMINO ACID BLOOD LEVEL; ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HYPERHOMOCYSTEINEMIA; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; MENTAL PATIENT; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RISK FACTOR; SCHIZOPHRENIA;

ADOLESCENT; ADULT; AGE FACTORS; AGED; ANALYSIS OF VARIANCE; CHRONIC DISEASE; FEMALE; HOMOCYSTEINE; HUMANS; MALE; MIDDLE AGED; SCHIZOPHRENIA; SEX FACTORS;

EID: 0036787407     PISSN: 0002953X     EISSN: None     Source Type: Journal    
DOI: 10.1176/appi.ajp.159.10.1790     Document Type: Article

References (14)

1. Nygard O, Vollset SE, Refsum H, Stevsvold I, Tverdal A, Nordrehaug JE, Ueland PM, Kvale G: Total plasma homocysteine and cardiovascular risk profile. JAMA 1995; 274:1526-1533
2. Seshadri S, Beiser A, Selhub J, Jacques PF, Rosenberg IH, D'Agostino B, Wilson PWF, Wolf PA: Plasma homocysteine as a risk factor for dementia and Alzheimer's disease. N Engl J Med 2002; 346:476-483
3. Kruman II, Culmsee C, Chan SL, Kruman Y, Guo Z, Penix L, Mattson MP: Homocysteine elicits a DNA damage response in neurons that promotes apoptosis and hypersensitivity to excitotoxicity. J Neurosci 2000; 20:6920-6926
4. Pollin W, Cardon P, Kety S: Effect of amino acid feedings in schizophrenic patients treated with iproniazid. Science 1961; 133:104-105
5. Regland B, Johansson BV, Gottfries CG: Homocystinemia and schizophrenia as a case of methylation deficiency. J Neural Transm 1994; 98:143-152
6. Regland B, Johansson BV, Grenfeldt B, Hjelmgren LT, Medhus M: Homocystinemia is a common feature of schizophrenia. J Neural Transm 1995; 100:165-169
7. Regland B, Germgard T, Gottfries CG, Grenfeldt B, Koch-Schmidt AC: Homozygous thermolabile methylene-tetrahydrofolate reductase in schizophrenia like psychosis. J Neural Transm 1997; 104:931-941
8. Susser E, Brown AS, Klonowski E, Allen RH, Lindenbaum J: Schizophrenia and impaired homocysteine metabolism: a possible association. Biol Psychiatry 1998; 44:141-143
9. Araki A, Sako Y: Determination of free and total homocysteine in human plasma by high-performance liquid chromatography with fluorescence detection. J Chromatogr 1987; 422:43-52
10. Virgos C, Martorell L, Simo JM, Valero J, Figuera L, Joven J, Labad A, Vilella E: Plasma homocysteine and the methylenetetrahydrofolate reductase C677T gene variant: lack of association with schizophrenia. Neuroreport 1999; 10:2035-2038
11. Lipton SA, Kim W-K, Choi Y-B, Kumar S, D'Emilia DM, Rayadu PV, Arnelle DR, Stamler JS: Neurotoxicity associated with dual actions of homocysteine at the N-methyl-D-aspartate receptor. Proc Natl Acad Sci USA 1997; 94:5923-5928
12. Friedman A, Kaufer D, Shemer J, Hendler I, Soreq H, Tur-Kaspa I: Pyridostigmine brain penetration under stress enhances neuronal excitability and induces immediate transcriptional response. Nat Med 1996; 2:1382-1385
13. Walter JH, Wraith JE, White FJ, Bridge C, Till J: Strategies for the treatment of cystathionine β-synthase deficiency: the experience of the Willink Biochemical Genetics Unit over the past 30 years. Eur J Pediatr 1998; 157:(suppl 2):S71-S76
14. Spence JK, Howard VJ, Chambless LE, Malinow MR, Pettigrew LC, Stampfer M, Toole LE: Vitamin intervention for stroke prevention (VISP) trial: rationale and design. Neuroepidemiology 2001; 20:16-25